Page last updated: 2024-10-28

lidocaine and Hepatitis A

lidocaine has been researched along with Hepatitis A in 2 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Hepatitis A: INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.

Research Excerpts

ExcerptRelevanceReference
" The absence of correlation between pharmacokinetic parameters of the disposition of lidocaine and indocyanine green indicates that the influence of hepatic disease on the hepatic processes that lead to the elimination of each compound is not predictable."1.26Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green. ( Blaschke, TF; Meffin, PJ; Melmon, KL; Rowland, M; Williams, RL, 1976)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muñoz, AE1
Miguez, C1
Rubio, M1
Bartellini, M1
Levi, D1
Podestá, A1
Niselman, V1
Terg, R1
Williams, RL1
Blaschke, TF1
Meffin, PJ1
Melmon, KL1
Rowland, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569]Phase 3120 participants (Anticipated)Interventional2005-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for lidocaine and Hepatitis A

ArticleYear
Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:4

    Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Bilirubin; Female; Half-Life; H

1999

Other Studies

1 other study available for lidocaine and Hepatitis A

ArticleYear
Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Clinical pharmacology and therapeutics, 1976, Volume: 20, Issue:3

    Topics: Acute Disease; Adult; Half-Life; Hepatitis A; Humans; Indocyanine Green; Kinetics; Lidocaine; Liver;

1976